Cardiomyopathy Trial, Recruiting NCT06887140 Sponsor: University Medical Center Ho Chi Minh City (UMC) Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT06887140
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with sepsis (a serious infection-related illness affecting the whole body)
  • People who received care in the Intensive Care Unit (ICU) at the University Medical Center in Ho Chi Minh City during the study period

Who may not be able to join:

  • People who are pregnant
  • People who have a history of a heart attack affecting the right side of the heart (right ventricular myocardial infarction)
  • People who have had an acute coronary syndrome (a sudden, serious heart condition such as a heart attack or unstable angina) within the past week
  • People who have heart valve disease or have previously had heart valve replacement surgery
  • People who have a congenital heart condition (a heart problem present from birth) or a condition where blood flows abnormally between the chambers of the heart (intracardiac shunt)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Khoi M Le, A/Prof. Dr., University Medical Center Ho Chi Minh City

Phone: +84907216232

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Medical Center Ho Chi Minh City (UMC)
Registry
ClinicalTrials.gov
Start date
16 April 2025
Est. completion
1 February 2027

Where this trial is recruiting

🇻🇳 Vietnam

Primary endpoints

In-hospital mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov